SANTA CLARA, California – Affymetrix Inc. (NASDAQ: AFFX)announced that it has received a grant from Innovate UK (IUK) to demonstrate the health and economic value of utilizing the company’s OncoScan® FFPE Assay Kit for non-invasive genomic profiling of bladder cancer from urine samples. Bladder cancer is the seventh most common cancer in the western world, […]

Oakland – Omicia Inc. will launch its new ACMG-scoring module for the Opal Clinical™ interpretation and reporting software platform at the ACMG Annual Clinical Genetics Meeting in Tampa,March 8-12th. This functionality provides an intuitive interface and workflow for clinical testing labs to systematically assess the disease-causing potential of genetic variants using the evidence-based classification system […]

SANTA CLARA, Calif., and HOUSTON — Agilent Technologies Inc. (NYSE: A) and Lasergen, Inc. announced that Agilent is investing $80 million in Lasergen, an emerging biotechnology company with innovative next-generation sequencing technology. With this investment, Agilent will acquire a 48-percent ownership stake in privately held Lasergen and will join the board. Agilent has the option […]

HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic (IVD) in the European Union. With the CE IVD mark, medical practitioners in Europe can use […]

WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, is now offering the first test kits available in the U.S. to enable serological detection of the Zika virus in research applications. The kits, manufactured by EUROIMMUN AG, can differentiate between Zika, dengue and chikungunya viruses. These tests also enable researchers to […]

Toronto, Ontario — SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced the following management changes. On the recommendation of President and CEO Andrew Morris, SQI’s Board of Directors has approved the promotion of Ms. […]

WALTHAM, Mass. (USA) and Chennai (INDIA) — PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, has expanded its footprint in India with the opening of a new diagnostics facility in Chennai, Tamil Nadu. The laboratory will provide a comprehensive menu of diagnostic screening services to hospitals, […]

CAMBRIDGE, Mass. — Seven Bridges, the biomedical data analysis company, announced that the system it was selected to develop as part of the National Cancer Institute’s Cloud pilot program is open to researchers worldwide. The Seven Bridges Cancer Genomics Cloud is the first complete ecosystem to give cancer researchers immediate access to one of the […]

CAMBRIDGE, Mass. — Seven Bridges, the biomedical data analysis company, announced $45 million in Series A fundraising, led by Kryssen Capital, an international investment fund that focuses on data-driven ventures at the cutting edge of science. The investment will support ongoing innovation of the Seven Bridges Platform, a scalable, cloud-based suite of tools for biomedical […]

LAUSANNE, Switzerland – Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT). Under the terms of the agreement, Sophia Genetics will combine its Sophia DDM™ analytics platform with IDT’s NGS target capture products. The new bundle will create the most advanced […]